Randomized Phase 2 Studies of Checkpoint Inhibitors Alone or in Combination With Pegilodecakin in Patients With Metastatic NSCLC (CYPRESS 1 and CYPRESS 2)

David R. Spigel, Robert M. Jotte, John Nemunaitis, M. Shum, Jeffrey Schneider, Jerome H. Goldschmidt, Jennifer Eisenstein, David Berz, Lasika Seneviratne, Matei P. Socoteanu, Viralkumar K. Bhanderi, Kartik Konduri, Meng Xia, Hong Wang, Rebecca R. Hozak, Ivelina Gueorguieva, David Ferry, Leena Gandhi, Bo H. Chao, Igor I. Rybkin